Alphatec Holdings, Inc. (ATEC)
11.11
-0.25
(-2.20%)
USD |
NASDAQ |
Oct 23, 16:00
11.06
-0.05
(-0.45%)
After-Hours: 20:00
Alphatec Holdings Enterprise Value : 2.205B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.205B |
| October 22, 2026 | 2.243B |
| October 21, 2026 | 2.167B |
| October 20, 2026 | 2.167B |
| October 19, 2026 | 2.098B |
| October 16, 2026 | 2.106B |
| October 15, 2026 | 2.178B |
| October 14, 2026 | 2.103B |
| October 13, 2026 | 2.161B |
| October 12, 2026 | 2.227B |
| October 09, 2026 | 2.138B |
| October 08, 2026 | 2.089B |
| October 07, 2026 | 2.074B |
| October 06, 2026 | 2.118B |
| October 05, 2026 | 2.146B |
| October 02, 2026 | 2.040B |
| October 01, 2026 | 2.021B |
| September 30, 2026 | 2.085B |
| September 29, 2026 | 2.092B |
| September 28, 2026 | 2.043B |
| September 25, 2026 | 2.054B |
| September 24, 2026 | 2.024B |
| September 23, 2026 | 2.040B |
| September 22, 2026 | 2.086B |
| September 21, 2026 | 2.062B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.063B |
| September 17, 2026 | 2.079B |
| September 16, 2026 | 2.112B |
| September 15, 2026 | 2.137B |
| September 14, 2026 | 2.167B |
| September 11, 2026 | 2.124B |
| September 10, 2026 | 1.859B |
| September 09, 2026 | 1.881B |
| September 08, 2026 | 1.912B |
| September 04, 2026 | 1.952B |
| September 03, 2026 | 1.933B |
| September 02, 2026 | 1.912B |
| September 01, 2026 | 1.915B |
| August 31, 2026 | 1.940B |
| August 28, 2026 | 1.950B |
| August 27, 2026 | 1.970B |
| August 26, 2026 | 1.947B |
| August 25, 2026 | 1.933B |
| August 24, 2026 | 1.920B |
| August 21, 2026 | 1.956B |
| August 20, 2026 | 1.927B |
| August 19, 2026 | 1.998B |
| August 18, 2026 | 1.964B |
| August 17, 2026 | 1.952B |
| August 14, 2026 | 2.004B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Artivion, Inc. | 1.465B |
| Glaukos Corp. | 10.35B |
| TransMedics Group, Inc. | 2.845B |
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.78M |
| Revenue (Quarterly) | 213.51M |
| Total Expenses (Quarterly) | 239.29M |
| EPS Diluted (Quarterly) | -0.1647 |
| Gross Profit Margin (Quarterly) | 62.90% |
| Profit Margin (Quarterly) | -12.07% |
| Earnings Yield | -6.45% |
| Normalized Earnings Yield | -5.537 |